| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-011053 |
| cik | 1603454 |
| name | CELCUITY INC. |
| sic | 8071 |
| countryba | US |
| stprba | MN |
| cityba | MINNEAPOLIS |
| zipba | 55446 |
| bas1 | 16305 36TH AVENUE N |
| bas2 | SUITE 100 |
| baph | 763-392-0767 |
| countryma | US |
| stprma | MN |
| cityma | MINNEAPOLIS |
| zipma | 55446 |
| mas1 | 16305 36TH AVENUE N |
| mas2 | SUITE 100 |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | CELCUITY LLC |
| changed | 20140324 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 17:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-011053 | 20250331 | Accounts Payable Current | 9932000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1331000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Change In Accrued Interest Income | 154000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20250331 | Deferred Financing Costs And Offering And Registration Statement Costs Included In Accounts Payable | USD | 1 | 0001641172-25-011053 | ||||
| 0001641172-25-011053 | 20240331 | General And Administrative Expense | 1846000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -21612000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Investment Income Interest | 2319000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Liabilities | 129504000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20240331 | Net Income Loss | -21612000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-011053 | 20241231 | Operating Lease Liability Noncurrent | 54000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Paid In Kind Interest | 249000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Shares Issued | 317577.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20250331 | Property And Equipment Included In Accounts Payable | USD | 1 | 0001641172-25-011053 | ||||
| 0001641172-25-011053 | 20240331 | Share Based Compensation | 832000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0001641172-25-011053 | 20250331 | Share Based Compensation | 2444000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Short Term Investments | 189213000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20231231 | Stockholders Equity | -160076000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20240331 | Stockholders Equity | 315393000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Stockholders Equity | -181688000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20250331 | Stockholders Equity | -308852000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 239000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 239000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2444000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Amortization Of Financing Costs And Discounts | 551000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Assets Current | 217597000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 30663000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Common Stock Shares Issued | 37143242.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Earnings Per Share Basic | -0.6400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Warrants | USD | 1 | 0001641172-25-011053 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Increase Decrease In Accrued Liabilities | 633000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Interest Expense Nonoperating | 3183000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Liabilities Current | 32919000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Long Term Notes Payable | 98527000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20250331 | Net Income Loss | -36997000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20250331 | Payments For Secondary Registration Statement Costs | 46000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Payments To Acquire Investments | 42486000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Shares Outstanding | 317577.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Proceeds From Warrant Exercises | 5600000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Research And Development Expense | 20647000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20231231 | Stockholders Equity | 26000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 500.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Conversion Of Preferred To Common Stock | USD | 1 | 0001641172-25-011053 | ||||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Conversion Of Preferred To Common Stock | 3000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 43052757.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 33612054.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Accrued Liabilities Current | 22818000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Accrued Liabilities Current | 22185000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Additional Paid In Capital | 395482000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Assets | 218127000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 16478000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Deferred Financing Costs And Offering And Registration Statement Costs Included In Accounts Payable | 13000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20240331 | Depreciation | 30000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Depreciation | 37000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Earnings Per Share Diluted | -0.8600 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Warrants | -14007000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Warrants | USD | 1 | 0001641172-25-011053 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -36997000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Increase Decrease In Accounts Payable | 238000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Investment Income Interest | 2282000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Liabilities Current | 31723000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Long Term Notes Payable | 97727000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Net Cash Provided By Used In Financing Activities | 5554000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Operating Expenses | 36133000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Operating Lease Liability Noncurrent | 13000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Other Assets Current | 9467000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Payments For Secondary Registration Statement Costs | 56000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Payments To Acquire Property Plant And Equipment | 60000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Shares Outstanding | 317577.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Retained Earnings Accumulated Deficit | -271855000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20231231 | Shares Outstanding | 25506012.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20231231 | Stockholders Equity | 139770000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Stockholders Equity | 395482000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Shares Conversion Of Preferred To Common Stock | 3488570.0000 | shares | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 2000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 33612054.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Additional Paid In Capital | 387437000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2444000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 31215000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 22515000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20241231 | Common Stock Shares Outstanding | 37143242.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Warrants | -14009000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Warrants | -2000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-011053 | 20240331 | Noncash Operating Lease Expense Net | 1000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Shares Authorized | 1850000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-011053 | 20250331 | Property And Equipment Included In Accrued Expenses | USD | 1 | 0001641172-25-011053 | ||||
| 0001641172-25-011053 | 20250331 | Retained Earnings Accumulated Deficit | -308852000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Share Based Compensation | 499000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0001641172-25-011053 | 20250331 | Share Based Compensation | 939000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0001641172-25-011053 | 20240331 | Shares Outstanding | 505277.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20241231 | Shares Outstanding | 317577.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20241231 | Short Term Investments | 212589000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Conversion Of Preferred To Common Stock | USD | 1 | 0001641172-25-011053 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1331000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Amortization Of Financing Costs And Discounts | 65000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Cash And Cash Equivalents At Carrying Value | 22515000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -6037000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Change In Accrued Interest Income | 946000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Common Stock Shares Authorized | 95000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Common Stock Value | 37000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Warrants | USD | 1 | 0001641172-25-011053 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Warrants | -5599000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20240331 | Exercise Of Stock Options Pending Receipt Of Cash Proceeds | 108000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Liabilities | 131459000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Cash Provided By Used In Investing Activities | 3536000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Paid In Kind Interest | 466000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Proceeds From Stock Options Exercised | 131000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Property And Equipment Included In Accounts Payable | 19000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20240331 | Property And Equipment Included In Accrued Expenses | 12000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Share Based Compensation | 1505000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0001641172-25-011053 | 20250331 | Shares Outstanding | 317577.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20231231 | Stockholders Equity | 299819000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20241231 | Stockholders Equity | 115619000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Stockholders Equity | 37000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 36550.0000 | shares | 1 | us-gaap/2024 | Derivative Instrument Risk= Employee Stock Option; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20241231 | Assets | 245123000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 552000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Earnings Per Share Basic | -0.8600 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Earnings Per Share Diluted | -0.6400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Exercise Of Common Stock Shares Warrants | 1742763.0000 | shares | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20250331 | Increase Decrease In Other Current Assets | 2436000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Net Cash Provided By Used In Operating Activities | -35853000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Net Income Loss | -36997000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Noncash Operating Lease Expense Net | -1000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Other Assets Current | 11906000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Shares Authorized | 2500000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Shares Authorized | 1850000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-011053 | 20250331 | Proceeds From Stock Options Exercised | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20240331 | Stockholders Equity | 31000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20241231 | Stockholders Equity | 387437000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20241231 | Stockholders Equity | -271855000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 36550.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 500.0000 | shares | 1 | us-gaap/2024 | Derivative Instrument Risk= Employee Stock Option; | ||
| 0001641172-25-011053 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Cash And Cash Equivalents At Carrying Value | 16478000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Common Stock Shares Authorized | 95000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Common Stock Value | 38000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Warrants | -1000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Warrants | USD | 1 | 0001641172-25-011053 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Increase Decrease In Accounts Payable | 613000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Liabilities And Stockholders Equity | 245123000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Cash Provided By Used In Financing Activities | 14084000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Net Cash Provided By Used In Investing Activities | 24262000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Cash Provided By Used In Operating Activities | -17068000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Net Income Loss | -21612000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Nonoperating Income Expense | 881000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Operating Income Loss | -22493000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Payments To Acquire Property Plant And Equipment | 90000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Proceeds From Sale And Maturity Of Other Investments | 125061000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Proceeds From Warrant Exercises | 14009000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Property Plant And Equipment Net | 336000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Shares Outstanding | 30773895.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20241231 | Shares Outstanding | 37143242.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Conversion Of Preferred To Common Stock | -3000.0000 | USD | 1 | 0001641172-25-011053 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20241231 | Accounts Payable Current | 9366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Assets Current | 244571000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Common Stock Shares Issued | 37839392.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Common Stock Shares Outstanding | 37839392.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Shares Warrants | 695650.0000 | shares | 1 | 0001641172-25-011053 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20250331 | Exercise Of Common Stock Warrants | -5600000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | Exercise Of Stock Options Pending Receipt Of Cash Proceeds | 2000.0000 | USD | 1 | 0001641172-25-011053 | |||
| 0001641172-25-011053 | 20250331 | General And Administrative Expense | 3906000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Increase Decrease In Accrued Liabilities | 2298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Increase Decrease In Other Current Assets | -269000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Interest Expense Nonoperating | 1401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Interest Paid Net | 870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Interest Paid Net | 2383000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Liabilities And Stockholders Equity | 218127000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | |||
| 0001641172-25-011053 | 20250331 | Nonoperating Income Expense | -864000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Operating Expenses | 22493000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Operating Income Loss | -36133000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Operating Lease Liability Current | 172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Operating Lease Liability Current | 169000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Operating Lease Right Of Use Asset | 216000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Operating Lease Right Of Use Asset | 172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Payments To Acquire Investments | 121435000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Shares Authorized | 2500000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Preferred Stock Shares Issued | 317577.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-011053 | 20250331 | Proceeds From Sale And Maturity Of Other Investments | 66808000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Proceeds From Warrant Exercises | 5600000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Property Plant And Equipment Net | 358000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Research And Development Expense | 32227000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20240331 | Share Based Compensation | 1331000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20231231 | Shares Outstanding | 854134.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20250331 | Shares Outstanding | 37839392.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Stockholders Equity | 133737000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Stockholders Equity | 86668000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Stockholders Equity | 38000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Shares Conversion Of Preferred To Common Stock | -348857.0000 | shares | 1 | 0001641172-25-011053 | Equity Components= Preferred Stock; | ||
| 0001641172-25-011053 | 20240331 | Stock Issued During Period Value Conversion Of Preferred To Common Stock | USD | 1 | 0001641172-25-011053 | Equity Components= Retained Earnings; | |||
| 0001641172-25-011053 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-011053 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 43052757.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Exercise Of Common Stock Shares Warrants | 0001641172-25-011053 | 1 | 0 | shares | D | Exercise of common stock warrants, net of shares withheld for exercise price, shares | Exercise of common stock warrants , shares. | |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Noncash Operating Lease Expense Net | 0001641172-25-011053 | 1 | 0 | monetary | D | D | Non-cash operating lease, net | Noncash operating lease expense net. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Payments To Acquire Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Exercise Of Stock Options Pending Receipt Of Cash Proceeds | 0001641172-25-011053 | 1 | 0 | monetary | D | C | Exercise of stock options pending receipt of cash proceeds | Exercise of stock options pending receipt of cash proceeds. |
| Deferred Financing Costs And Offering And Registration Statement Costs Included In Accounts Payable | 0001641172-25-011053 | 1 | 0 | monetary | D | C | Deferred financing costs and offering and registration statement costs included in accounts payable | Deferred financing costs and offering and registration statement costs included in accounts payable. |
| Stock Issued During Period Value Conversion Of Preferred To Common Stock | 0001641172-25-011053 | 1 | 0 | monetary | D | C | Conversion of preferred to common stock | Conversion of preferred to common stock. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Paid In Kind Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Paid-in-Kind Interest | Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Property And Equipment Included In Accounts Payable | 0001641172-25-011053 | 1 | 0 | monetary | D | C | Property and equipment included in accounts payable | Property and equipment included in accounts payable. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Payments For Secondary Registration Statement Costs | 0001641172-25-011053 | 1 | 0 | monetary | D | C | PaymentsForSecondaryRegistrationStatementCosts | Payments for secondary registration statement costs. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Change In Accrued Interest Income | 0001641172-25-011053 | 1 | 0 | monetary | D | C | ChangeInAccruedInterestIncome | Change in accrued interest income. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Increase Decrease In Other Current Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Current Assets | Amount of increase (decrease) in current assets classified as other. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Sale And Maturity Of Other Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Other Investments | The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Property And Equipment Included In Accrued Expenses | 0001641172-25-011053 | 1 | 0 | monetary | D | C | Property and equipment included in accrued expenses | Property and equipment included in accrued expenses. |
| Exercise Of Common Stock Warrants | 0001641172-25-011053 | 1 | 0 | monetary | D | C | ExerciseOfCommonStockWarrants | Exercise of common stock warrants. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Stock Issued During Period Shares Conversion Of Preferred To Common Stock | 0001641172-25-011053 | 1 | 0 | shares | D | Conversion of preferred to common stock, shares | Conversion of preferred to common stock, shares. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-011053 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-011053 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Investments | 0 |
| 0001641172-25-011053 | 2 | 5 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Other current assets | 0 |
| 0001641172-25-011053 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-011053 | 2 | 7 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001641172-25-011053 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001641172-25-011053 | 2 | 9 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001641172-25-011053 | 2 | 12 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-011053 | 2 | 13 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001641172-25-011053 | 2 | 14 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001641172-25-011053 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-011053 | 2 | 16 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001641172-25-011053 | 2 | 17 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Note payable, non-current | 0 |
| 0001641172-25-011053 | 2 | 18 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0001641172-25-011053 | 2 | 19 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 5) | 0 |
| 0001641172-25-011053 | 2 | 20 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value: 2,500,000 shares authorized; 317,577 shares issued and outstanding as of each of March 31, 2025 and December 31, 2024 | 0 |
| 0001641172-25-011053 | 2 | 21 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value: 95,000,000 shares authorized; 37,839,392 and 37,143,242 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001641172-25-011053 | 2 | 22 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-011053 | 2 | 23 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-011053 | 2 | 24 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders Equity | 0 |
| 0001641172-25-011053 | 2 | 25 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Equity | 0 |
| 0001641172-25-011053 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-011053 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-011053 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-011053 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-011053 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-011053 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-011053 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-011053 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-011053 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-011053 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-011053 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-011053 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001641172-25-011053 | 4 | 7 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001641172-25-011053 | 4 | 8 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0001641172-25-011053 | 4 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Other (expense) income, net | 0 |
| 0001641172-25-011053 | 4 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net loss before income taxes | 0 |
| 0001641172-25-011053 | 4 | 11 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax benefits | 0 |
| 0001641172-25-011053 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-011053 | 4 | 13 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share, basic | 0 |
| 0001641172-25-011053 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, diluted | 0 |
| 0001641172-25-011053 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average common shares outstanding, basic | 0 |
| 0001641172-25-011053 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common shares outstanding, diluted | 0 |
| 0001641172-25-011053 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-011053 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-011053 | 5 | 11 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-011053 | 5 | 12 | EQ | 0 | H | Exercise Of Common Stock Warrants | 0001641172-25-011053 | Exercise of common stock warrants, net of shares withheld for exercise price | 1 |
| 0001641172-25-011053 | 5 | 13 | EQ | 0 | H | Exercise Of Common Stock Shares Warrants | 0001641172-25-011053 | Exercise of common stock warrants, net of shares withheld for exercise price, shares | 0 |
| 0001641172-25-011053 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of common stock options, net of shares withheld for exercise price | 0 |
| 0001641172-25-011053 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of common stock options, net of shares withheld for exercise price, shares | 0 |
| 0001641172-25-011053 | 5 | 16 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-011053 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Preferred To Common Stock | 0001641172-25-011053 | Conversion of preferred to common stock | 0 |
| 0001641172-25-011053 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Preferred To Common Stock | 0001641172-25-011053 | Conversion of preferred to common stock, shares | 0 |
| 0001641172-25-011053 | 5 | 19 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-011053 | 5 | 20 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-011053 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-011053 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001641172-25-011053 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-011053 | 6 | 6 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization of debt issuance costs and discount | 0 |
| 0001641172-25-011053 | 6 | 7 | CF | 0 | H | Paid In Kind Interest | us-gaap/2024 | Payment-in-Kind interest | 0 |
| 0001641172-25-011053 | 6 | 8 | CF | 0 | H | Noncash Operating Lease Expense Net | 0001641172-25-011053 | Non-cash operating lease, net | 0 |
| 0001641172-25-011053 | 6 | 9 | CF | 0 | H | Change In Accrued Interest Income | 0001641172-25-011053 | Change in accrued interest income | 1 |
| 0001641172-25-011053 | 6 | 11 | CF | 0 | H | Increase Decrease In Other Current Assets | us-gaap/2024 | Other current assets | 1 |
| 0001641172-25-011053 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-011053 | 6 | 13 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001641172-25-011053 | 6 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used for operating activities | 0 |
| 0001641172-25-011053 | 6 | 16 | CF | 0 | H | Proceeds From Sale And Maturity Of Other Investments | us-gaap/2024 | Proceeds from maturities of investments | 0 |
| 0001641172-25-011053 | 6 | 17 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Purchases of investments | 1 |
| 0001641172-25-011053 | 6 | 18 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0001641172-25-011053 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001641172-25-011053 | 6 | 21 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from exercise of common stock warrants | 0 |
| 0001641172-25-011053 | 6 | 22 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of employee stock options | 0 |
| 0001641172-25-011053 | 6 | 23 | CF | 0 | H | Payments For Secondary Registration Statement Costs | 0001641172-25-011053 | Payments for secondary registration statement costs | 1 |
| 0001641172-25-011053 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001641172-25-011053 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents | 0 |
| 0001641172-25-011053 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Beginning of period | 0 |
| 0001641172-25-011053 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | End of period | 0 |
| 0001641172-25-011053 | 6 | 30 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
| 0001641172-25-011053 | 6 | 32 | CF | 0 | H | Deferred Financing Costs And Offering And Registration Statement Costs Included In Accounts Payable | 0001641172-25-011053 | Deferred financing costs and offering and registration statement costs included in accounts payable | 0 |
| 0001641172-25-011053 | 6 | 33 | CF | 0 | H | Property And Equipment Included In Accounts Payable | 0001641172-25-011053 | Property and equipment included in accounts payable | 0 |
| 0001641172-25-011053 | 6 | 34 | CF | 0 | H | Property And Equipment Included In Accrued Expenses | 0001641172-25-011053 | Property and equipment included in accrued expenses | 0 |
| 0001641172-25-011053 | 6 | 35 | CF | 0 | H | Exercise Of Stock Options Pending Receipt Of Cash Proceeds | 0001641172-25-011053 | Exercise of stock options pending receipt of cash proceeds | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |